Assignee
DOUGLAS PHARMACEUTICALS LTD
NZ·13 granted patents·12 pending applications·61 citations·filing 2012–2025
Top patents by PatentIndex Score
25 records- 0195US10869838B2Extended release pharmaceutical formulationDOUGLAS PHARMACEUTICALS LTD·Filed 2019·Granted Dec 22, 2020·11 cites·32 claims
- 0295US10744094B2Extended release pharmaceutical formulationDOUGLAS PHARMACEUTICALS LTD·Filed 2019·Granted Aug 18, 2020·12 cites·13 claims
- 0395US10441544B2Extended release pharmaceutical formulationDOUGLAS PHARMACEUTICALS LTD·Filed 2017·Granted Oct 15, 2019·15 cites·11 claims
- 0494US11045424B2Extended release pharmaceutical formulationDOUGLAS PHARMACEUTICALS LTD·Filed 2019·Granted Jun 29, 2021·9 cites·13 claims
- 0590US12090123B2Extended release pharmaceutical formulationDOUGLAS PHARMACEUTICALS LTD·Filed 2020·Granted Sep 17, 2024·3 cites·20 claims
- 0689US12128140B2Extended release pharmaceutical formulationDOUGLAS PHARMACEUTICALS LTD·Filed 2020·Granted Oct 29, 2024·2 cites·66 claims
- 0787US11471415B2Extended release pharmaceutical formulation and methods of treatmentDOUGLAS PHARMACEUTICALS LTD·Filed 2018·Granted Oct 18, 2022·6 cites·22 claims
- 0885US11738024B2Lopinavir and ritonavir for the treatment of cervix disordersDOUGLAS PHARMACEUTICALS LTD·Filed 2019·Granted Aug 29, 2023·2 cites·18 claims
- 0981US12083120B2TreatmentsDOUGLAS PHARMACEUTICALS LTD·Filed 2019·Granted Sep 10, 2024·1 cites·6 claims
- 1074US12472146B2Extended release pharmaceutical formulationDOUGLAS PHARMACEUTICALS LTD·Filed 2022·Granted Nov 18, 2025·0 cites·22 claims
- 1174US2025025464A1TreatmentsDOUGLAS PHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 1273US12350378B2Extended release pharmaceutical formulation and methods of treatmentDOUGLAS PHARMACEUTICALS LTD·Filed 2022·Granted Jul 8, 2025·0 cites·21 claims
- 1370US2024148729A1Lopinavir and ritonavir for the treatment of cervix disordersDOUGLAS PHARMACEUTICALS LTD·Filed 2023·Application pending·0 cites
- 1469US12350379B2Extended release pharmaceutical formulation and methods of treatmentDOUGLAS PHARMACEUTICALS LTD·Filed 2022·Granted Jul 8, 2025·0 cites·23 claims
- 1568US2026034224A1Compositions comprising lopinavir and treatment of conditionsDOUGLAS PHARMACEUTICALS LTD·Filed 2025·Application pending·0 cites
- 1664US2025049734A1Extended release pharmaceutical formulationDOUGLAS PHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 1763US2026096996A1Pharmaceutical compositions of tretinoin and methods of producing such compositionsDOUGLAS PHARMACEUTICALS LTD·Filed 2023·Application pending·0 cites
- 1862US2026034065A1Extended release pharmaceutical formulationDOUGLAS PHARMACEUTICALS LTD·Filed 2025·Application pending·0 cites
- 1961US2024189259A2Extended Release Pharmaceutical FormulationDOUGLAS PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 2060US2025064816A1Pharmaceutical rectal suppository compositions of 6-thioguanine, methods of treatment and/or methods of manufacturingDOUGLAS PHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 2159US12414994B2Compositions comprising lopinavir and treatment of conditionsDOUGLAS PHARMACEUTICALS LTD·Filed 2020·Granted Sep 16, 2025·0 cites·19 claims
- 2258US2025213580A1Improved Thiopurine Formulation and Treatment MethodsDOUGLAS PHARMACEUTICALS LTD·Filed 2023·Application pending·0 cites
- 2354US2026076912A1Pharmaceutical compositions and methodsDOUGLAS PHARMACEUTICALS LTD·Filed 2025·Application pending·0 cites
- 2448US2014234430A1Pharmaceutical methods and topical compositions containing acitretinDOUGLAS PHARMACEUTICALS LTD·Filed 2012·Application pending·0 cites
- 2544US2023285287A1Pharmaceutical compositionsDOUGLAS PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DOUGLAS PHARMACEUTICALS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →